In these cases, omissions or errors in the medication order may lead to dispensing from the wrong drug supply at the time orders are filled. Lastly, in the investigational study setting ...

Pharmaceutical companies often have a limited supply of an investigational drug, which may not be sufficient to meet the demand from both clinical trials and EAPs. 4 This raises difficult ...

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer. Researchers at Washington University School of Medicine in St. Louis, MO, have ...

today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) to initiate a clinical study of the company’s investigational UKidney ...

New Delhi: Dr Reddy’s Laboratories on Thursday said its subsidiary has inked a licence agreement with Shanghai Henlius ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

An NIH report, ‘Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design’, highlighted that in June 2022 approximately 41% of pharmaceutical companies experienced supply ...

The drug’s safety profile in this specific patient population will also be established. “The trial will be using state-of-the art, continuous measurements of nighttime BP to generate thousands ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application ...

A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study's safety review committee (SRC) reviewed the data from ...

Celltrion launches ADC cancer drug trials in U.S. while planning additional INDs Celltrion accelerates its global drug ...

Wockhardt's Zaynich, an investigational antibiotic, has been under evaluation for its efficacy in treating complicated ...